Trump May Try to Force Drugmakers to Match European Pricesnews2025-09-26T02:13:57+00:00September 26th, 2025|The New York Times|
Times Reporters Answer Your Vaccine Questionsnews2025-09-25T11:17:58+00:00September 25th, 2025|The New York Times|
Un decano de Harvard cobró 150.000 dólares como perito en las demandas contra Tylenolnews2025-09-24T18:51:33+00:00September 24th, 2025|The New York Times|
The Billionaire, the Psychedelics and the Best-Selling Memoirnews2025-09-24T07:00:18+00:00September 24th, 2025|The New York Times|
F.D.A.’s Approval of a Drug for Autism Upends Review Processnews2025-09-23T23:09:46+00:00September 23rd, 2025|The New York Times|
Harvard Dean Was Paid $150,000 as an Expert Witness in Tylenol Lawsuitsnews2025-09-23T21:57:24+00:00September 23rd, 2025|The New York Times|
4 Autism Experts React to Trump’s Plannews2025-09-23T18:50:52+00:00September 23rd, 2025|The New York Times|
Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisisnews2025-09-23T04:39:03+00:00September 23rd, 2025|The New York Times|
La empresa detrás de Tylenol intenta sortear su crisis más recientenews2025-09-23T04:01:05+00:00September 23rd, 2025|The New York Times|
These Patients Got the Cure. Then It Went Away.news2025-09-22T22:35:25+00:00September 22nd, 2025|The New York Times|
